Basal-IQ technology increased device satisfaction in former MDI and non-Tandem pump users, and sustained satisfaction across all user groups. Additionally, a reduction in diabetes impact was observed ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, announced results from a prospective, multicenter, single-arm study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results